Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

3 256 evidences · page 8 / 131

87,7 %Les adénopathies supérieures à un centimètre représentaient 87,7 % des adénopathies malignes.

Gabonadénopathies malignespublié 2018Health sciences and diseaseOpenAlexdocument de 9 observations

150 mf/mLThe median Loa loa parasitaemia in people living with HIV receiving cotrimoxazole prophylaxis was 150 mf/mL (interquartile range 125–350).

Gabonloasepublié 2022Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument de 10 observations

44 %The overall prevalence of soil-transmitted helminth (STH) infections was 44% at baseline for the nine-month follow-up period.

Gabonsoil-transmitted helminth (STH) infectionspublié 2024Tropical medicine and healtheurope_pmcdocument de 9 observationsDOI 10.1186/s41182-023-00567-z

40,1 odds_ratioChildren living on or near the Mindoubé landfill site were more likely to develop ENT pathology with an odds ratio of 40.1.

GabonENT pathologypublié 2024Asian Journal of Pediatric ResearchOpenAlexdocument de 5 observationsDOI 10.9734/ajpr/2024/v14i1318

69,6 %Malaria infection prevalence was 69.6% among school-aged children in Gabon.

Gabonpaludismeobservé 2021publié 2024Tropical medicine and infectious diseaseeurope_pmcdocument de 8 observationsDOI 10.3390/tropicalmed10010011

59 %After 28 days, 59% of participants in the Individual Treatment group were clinically cured.

Gabonscabiespublié 2020PLoS neglected tropical diseaseseurope_pmcdocument de 4 observationsDOI 10.1371/journal.pntd.0008423

45,9 %For low-level parasitemias, venous blood microscopy sensitivity dropped to 45.9%.

Gabonpaludismeobservé 2015–2016publié 2018The Journal of infectious diseaseseurope_pmcdocument de 8 observationsDOI 10.1093/infdis/jiy319

4,7 %Subtype F accounted for 4.7% of HIV-1 cases in the studied population in Gabon.

GabonVIH/sidapublié 2012BMC Infectious DiseasesOpenAlexdocument de 14 observationsDOI 10.1186/1471-2334-12-64

10,3 %The wild-type D1246 Pfmdr1 genotype prevalence was 10.3% in symptomatic infections and 100% in asymptomatic infections.

Gabonpaludismepublié 2021Infection and drug resistanceeurope_pmcdocument de 10 observationsDOI 10.2147/idr.s304361

4 %In an efficacy open-label clinical trial with a 28-day follow-up in 29 children under five with uncomplicated malaria, PCR-corrected, 1/26 (4%) had an early treatment failure, resulting in early trial discontinuation.

Gabonpaludismepublié 2011Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/1475-2875-10-123

78,8 %In study A, the specificity of the Schistoscope was 78.8% based on the composite reference standard.

Gabonschistosomiasepublié 2024PLoS neglected tropical diseaseseurope_pmcdocument de 10 observationsDOI 10.1371/journal.pntd.0011967

36,4 %The therapeutic success rate among pre-XDR patients was 4 (36.4%).

Gabonpre-XDR TBobservé 2019 to 2022publié 2024Revue des maladies respiratoiresPubMeddocument de 15 observations

The cumulative HPV viral loads of any HPV and high-risk HPV in ICC were significantly higher than those in CIN2/3 (p < 0.002 for any HPV; p = 0.02 for HR-HPV).

Gabonhigh-risk HPV · ICC · infection à HPV · lésions précancéreuses du col (CIN)publié 2025Health science reportsPubMeddocument de 3 observations

2,2 odds_ratioThe association between high blood pressure and diabetes significantly increased the risk of death in heart failure patients (OR = 2.2, 95% CI: 1.2–6.6).

Gabondiabète (non précisé) · hypertension artérielle · insuffisance cardiaqueobservé January 2014 to December 2016publié 2018The Pan African medical journalPubMeddocument de 9 observations

20 000 000 infectionsMore than 20 million people are infected with L. loa.

GabonL. loa · loasepublié 2024PLoS neglected tropical diseaseseurope_pmcdocument de 7 observations

20 copiesThe RT-LAMP assay successfully detected 20–50 copies of the SARS-CoV-2 viral genome within 15 minutes, regardless of the variant.

GabonCOVID-19publié 2022PLoS neglected tropical diseaseseurope_pmcdocument de 3 observationsDOI 10.1371/journal.pntd.0010964

6,5 %Vaccine efficacy of GMZ2/alum was 6.5% against clinical malaria over 24 months in the intention-to-treat analysis.

Gabonpaludismepublié 2021VaccinePubMeddocument de 3 observations

1,2 %Human coronavirus OC43 was detected in 1.2% of the 156 respiratory virus-positive nasopharyngeal swab specimens collected in Gabon from March 2020 to July 2021.

Gabonhuman coronavirus OC43observé March 2020 to July 2021publié 2024Viruseseurope_pmcdocument de 8 observations

24,6 %WNV-specific IgG prevalence was 24.6% in females in Gabon.

GabonWest Nile viruspublié 2010Virology JournalOpenAlexdocument de 6 observationsDOI 10.1186/1743-422x-7-132

31 yearsThe mean and median age of the patients was 31 years in the study on vulvovaginal candidiasis near Franceville, Gabon.

Gabonvulvovaginal candidiasispublié 2023Journal de mycologie medicaleeurope_pmcdocument de 3 observations

52,8 %Le motif de l’avortement était une grossesse non désirée dans 52,8 % des cas d’avortement clandestin au Centre Hospitalier Universitaire de Libreville entre 2014 et 2018.

Gabonavortement clandestinobservé 2014 à 2018publié 2021Revue de médecine et de pharmacieOpenAlexdocument de 24 observations

0,45 adjusted_odds_ratioParity was associated with Plasmodium falciparum infection, with an adjusted odds ratio of 0.45 for multipara versus paucipara.

Gabonpaludismeobservé 2008–2011publié 2013Malaria JournalOpenAlexdocument de 6 observationsDOI 10.1186/1475-2875-12-412

20,75 %The global mixed rate of infections among infected individuals was 20.75% (11/53).

Gabonmixed trypanosome infectionpublié 2022Pathogens (Basel, Switzerland)europe_pmcdocument de 6 observationsDOI 10.3390/pathogens11090992

329 participantsAscaridiasis was present in 329 participants (43.0%).

GabonascariasisHAL · Unilimdocument de 153 observations

3,7 %Microfilariae were associated with increased moderate anemia (3.7% vs. 29%).

Gabonmicrofilaremia · moderate anaemiaobservé March 2018 to October 2019publié 2024Balkan medical journaleurope_pmcdocument de 7 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.